Increasing investment in R&D activities and rising adoption of laboratory automation systems are expected to boost the growth of the global laboratory automation market at a CAGR of 8.15% during the forecast period 2022 to 2030.

Market Research Future (MRFR) has published a cooked research report on the “Global Laboratory Automation Market” that contains the information from 2018 to 2030. The companion diagnostics market is projected to register a CAGR of 8.15% during the forecast period of 2022 to 2030.

MRFR recognizes the following companies as the key players in the global laboratory automation market— Beckman Coulter, Inc. (US), QIAGEN N.V. (Germany), Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), Tecan Trading AG (Switzerland), BioMérieux SA (France), Siemens Healthineers (Germany), PerkinElmer Inc. (US), Hamilton Company (US), F. Hoffmann-La Roche Ltd (Switzerland), and others.

Laboratory Automation Market Highlights

The global laboratory automation market is attributed to register a CAGR of 8.15% during the forecast period and is estimated to reach USD 10.92 billion by 2030.

Laboratory automation is a process of optimizing laboratory processes by atomizing instruments and software so that minimal human input is required to perform the tasks. There are several benefits of laboratory automation, such as reduced errors, short turnaround times, increased productivity, safer working conditions, and reduced costs. As medical technologies advance and healthcare infrastructure develop globally, there is an increasing demand for laboratory automation in order to increase laboratory efficiency and throughput.

The growth of the global laboratory automation market is attributed to the increasing investments in R&D activities and the rising adoption of laboratory automation systems. However, high initial capital investments in automating laboratory infrastructure are anticipated to hamper the market growth. Furthermore, factors like improving healthcare infrastructure across emerging countries are expected to drive market growth in the future.

Segment Analysis

The global laboratory automation market has been segmented based on product type, process, application, and end user.

On the basis of product type, the market is segmented into automated workstations, robotic systems, software & informatics, and others. The automated workstations further segmented into automated liquid handling, microplate readers, automated Elisa systems, automated nucleic acid purification systems moreover, software & informatics segmented into electronic laboratory notebook, workstation/unit automation software, scientific data management system, laboratory information management system.

Based on process, the global laboratory automation market has been bifurcated into continuous flow and discrete processing. The continuous flow segmented into workflow and components moreover, discrete processing further segmented into method, components, and workflow.

The global laboratory automation market, on the basis of application, has been segmented into clinical diagnostics, genomics solutions, proteomics solutions, drug discovery, and others.

Based on end user, the global laboratory automation market has been segmented into biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories, and research & academic institutes.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Laboratory Automation Market Research Report

Regional Analysis

The global laboratory automation market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe companion diagnostics market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The companion diagnostics market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World companion diagnostics market comprises of Middle East, Africa, and Latin America.

North America is attributed due to well-established biotechnology and biopharmaceutical sector and the high adoption rate of technologically advanced equipment for discovering new and effective drugs in the region are expected to drive the regional market growth during the forecast period.

Moreover, Europe accounts for the second-largest market share due to rising R&D activities in genomics and the growing demand for automated workstations, microplate readers, and cloud-based information systems from the healthcare sector such as hospitals and biotechnology & pharmaceutical companies are also expected to boost the market growth in the region.

The Asia-Pacific laboratory automation market is the fastest growing, owing to factors such as improved healthcare infrastructure, an increase in the number of pharmaceutical companies, and greater awareness of advanced laboratory automation systems.

The market for laboratory automation is growing in LAMEA, which includes Latin America, the Middle East, and Africa, owing to technological advancements in laboratory automation systems, rapidly improving healthcare infrastructure, and rising R&D in biotechnology and pharmaceutical companies.

Key Findings of the Study

• The global laboratory automation market is expected to reach USD 10.92 billion by 2030 at a CAGR of 8.15% during the forecast period.


• The Asia-Pacific region accounted for the fastest growing of the global market, owing to the rise in the number of pharmaceutical companies, and a surge in awareness about advanced laboratory automation systems supporting the market growth.


• Based on application, the clinical diagnostics segment held the largest market in 2021, with a market share of 32.36%, reaching a market value of USD 1.88 billion by 2030.


• Beckman Coulter, Inc. (US), QIAGEN N.V. (Germany), Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), Tecan Trading AG (Switzerland), BioMérieux SA (France), Siemens Healthineers (Germany), PerkinElmer Inc. (US), Hamilton Company (US), F. Hoffmann-La Roche Ltd (Switzerland), and others are the key market players.